Validation of urinary HE4 as a biomarker for ovarian cancer. This is an ASCO Meeting Abstract from the 2013 ASCO Annual Meeting I. This abstract does not include a full text component.
NICE, the healthcare guidance body, today (21 March) publishes final guidance supporting the use of a new device that can help reduce the severe abdominal fluid retention experienced by some cancer ...